About Euploid Pharmaceuticals Private Limited
Data last updated:
Euploid Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2015PTC081999. Its GSTIN is 29AAECE0214F1Z4 (Karnataka).
The company has an authorised share capital of ₹12 Cr and a paid-up capital of ₹6 Cr. It is led by directors Raju Chowdappa Raghavendra and Nagarani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 29/2 No 15 Vinayaka Layout K R Puram, Bangalore, Karnataka, India – 560049.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.26 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹6.06 Cr (net margin -268.3%) and EBITDA of -₹11.89 Lakh (EBITDA margin -5.3%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years and 32% over five years.
As per MCA filings, the company has open charges of ₹20 Cr and satisfied charges of ₹15.18 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website euploidpharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address29/2 No 15 Vinayaka Layout K R Puram, Bangalore, Karnataka, India – 560049
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Euploid Pharmaceuticals Private Limited
The main business activity of Euploid Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Euploid Pharmaceuticals Private Limited FY 2024 filings available
Euploid Pharmaceuticals Private Limited reported revenue of ₹2.26 Cr (up 276% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Euploid Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 276% growth in the latest year. EBITDA rose 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Euploid Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹11.89 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹6.06 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Euploid Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -268.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Euploid Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Euploid Pharmaceuticals Private Limited
Euploid Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| VJS Pharmaceuticals Private Limited | ₹2.28 Cr (FY 2020) | •••• | •••• | -9.0% | •••• | New Delhi, Delhi, India |
| Bhomiaji Unique Packaging Private Limited | ₹2.28 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Tuticorin, Tamil Nadu, India |
| Lexba Biotech Private Limited | ₹2.27 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Mumbai, Maharashtra, India |
| Aam India Pharmaceuticals Private Limited | ₹2.26 Cr (FY 2021) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Dermasculpt Health Care Private Limited | ₹2.26 Cr (FY 2025) | •••• | •••• | 54.0% | •••• | Bangalore, Karnataka, India |
| Euploid Pharmaceuticals Private Limited this company | ₹2.26 Cr (FY 2025) | •••• | •••• | 276.0% | •••• | Bangalore, Karnataka, India |
| Globentis International Private Limited | ₹2.26 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Ahmedabad, Gujarat, India |
| Bsure Pharmaceuticals Private Limited | ₹2.26 Cr (FY 2025) | •••• | •••• | 54.0% | •••• | Patna, Bihar, India |
| Likameda Pharmaceuticals Private Limited | ₹2.26 Cr (FY 2025) | •••• | •••• | 36.0% | •••• | Ahmedabad, Gujarat, India |
| Srushti Pharmaceuticals Private Limited | ₹2.26 Cr (FY 2025) | •••• | •••• | -56.0% | •••• | Bangalore, Karnataka, India |
| Anandeshwar Chemtech Private Limited | ₹2.25 Cr (FY 2025) | •••• | •••• | •••• | Bhadrsa, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Euploid Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Euploid Pharmaceuticals Private Limited
Euploid Pharmaceuticals Private Limited is audited by A R VISWANATHAN & CO for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A R VISWANATHAN & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Euploid Pharmaceuticals Private Limited
Euploid Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raju Chowdappa Raghavendra Also directs: Aryvenk Pharmatech Global Solutions Private Limited | Director | 04 Aug 2015 | 11 Years 2 Months | Current |
| Nagarani Also directs: Caspase Pharmaceuticals Private Limited | Director | 04 Jun 2024 | 2 Years 4 Months | Current |
Ownership and Shareholding of Euploid Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Euploid Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jul 2025 | City Union Bank Limited | ₹20 Cr | Open |
| 16 Feb 2022 | Canara Bank | ₹15.18 Cr | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Euploid Pharmaceuticals Private Limited
Euploid Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending. Status as checked on 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Court case (ID) | Filed against the company by an individual | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Euploid Pharmaceuticals Private Limited
Euploid Pharmaceuticals Private Limited has a workforce of 0 employees as of Dec 17, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Euploid Pharmaceuticals Private Limited
Euploid Pharmaceuticals Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Nagarani ceased to be Additional Director on 29 Sep 2024.
Credit Ratings, Litigation & Regulatory Alerts for Euploid Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Euploid Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Euploid Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Euploid Pharmaceuticals Private Limited
Euploid Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECE0214F1Z4 | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Euploid Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Euploid Pharmaceuticals Private Limited
Euploid Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 August 2015 (11+ years old) and is registered under CIN U24230KA2015PTC081999.
Euploid Pharmaceuticals reported revenue of ₹2.26 Cr for FY 2025 (up 276% YoY).
Euploid Pharmaceuticals has 2 current directors:
- Raju Chowdappa Raghavendra - Director
- Nagarani - Director
Euploid Pharmaceuticals reported a net loss of ₹6.06 Cr (net margin -268.3%) and EBITDA of -₹11.89 Lakh (EBITDA margin -5.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Euploid Pharmaceuticals is 42% over three years and 32% over five years. In the latest year (FY 2025) revenue rose 276%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Euploid Pharmaceuticals is 29AAECE0214F1Z4, registered in Karnataka.
The CIN (Corporate Identification Number) of Euploid Pharmaceuticals is U24230KA2015PTC081999. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Euploid Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Euploid Pharmaceuticals was incorporated on 04 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Euploid Pharmaceuticals by revenue are VJS Pharmaceuticals Private Limited, Bhomiaji Unique Packaging Private Limited, Lexba Biotech Private Limited, Aam India Pharmaceuticals Private Limited, Dermasculpt Health Care Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Nagarani ceased to be Additional Director on 29 Sep 2024. Nagarani was appointed as Director on 04 Jun 2024. Hanumappa Chowdappa ceased to be Additional Director on 31 Dec 2020. Euploid Pharmaceuticals has 5 board changes on record in total.